APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arginase 1 Antibody

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Arginase 1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchArginase 1 Antibody Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Arginase 1 Antibody Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Arginase 1 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arginase 1 Antibody Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Arginase 1 Antibody Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Arginase 1 Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Arginase 1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Arginase 1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arginase 1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Arginase 1 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Arginase 1 Antibody include Sino Biological, Inc., Wuhan Fine Biotech Co., Ltd., Shanghai Korain Biotech Co., Ltd., Thermo Fisher, ZodelBiotec Ltd., ZellBio GmbH, MyBiosource, Inc., Innovative Research and Geno Technology, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Arginase 1 Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Arginase 1 Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Arginase 1 Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Arginase 1 Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

Arginase 1 Antibody Segment by Company

Sino Biological, Inc.

Wuhan Fine Biotech Co., Ltd.

Shanghai Korain Biotech Co., Ltd.

Thermo Fisher

ZodelBiotec Ltd.

ZellBio GmbH

MyBiosource, Inc.

Innovative Research

Geno Technology, Inc.

CUSABIO

Creative Diagnostics

CLOUD-CLONE CORP.

Biomatik

Assay Genie

Abbexa

Arginase 1 Antibody Segment by Type

Monoclonal Antibody

Polyclonal Antibody

Arginase 1 Antibody Segment by Application

Immunofluorescence

Immunoprecipitation

ELISA

Flow Cytometry

Western Blot

Other

Arginase 1 Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arginase 1 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arginase 1 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arginase 1 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Arginase 1 Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Arginase 1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Arginase 1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Arginase 1 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Arginase 1 Antibody Industry Trends Table 2. Arginase 1 Antibody Industry Drivers Table 3. Arginase 1 Antibody Industry Opportunities and Challenges Table 4. Arginase 1 Antibody Industry Restraints Table 5. Global Arginase 1 Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Arginase 1 Antibody Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Arginase 1 Antibody Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Arginase 1 Antibody Sales Market Share by Manufacturers Table 9. Global Arginase 1 Antibody Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Arginase 1 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Arginase 1 Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Arginase 1 Antibody Manufacturers, Product Type & Application Table 13. Global Arginase 1 Antibody Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Arginase 1 Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Monoclonal Antibody Table 17. Major Manufacturers of Polyclonal Antibody Table 18. Global Arginase 1 Antibody Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Arginase 1 Antibody Sales by Type (2021-2026) & (k units) Table 20. Global Arginase 1 Antibody Sales by Type (2027-2032) & (k units) Table 21. Global Arginase 1 Antibody Sales Market Share by Type (2021-2026) Table 22. Global Arginase 1 Antibody Sales Market Share by Type (2027-2032) Table 23. Global Arginase 1 Antibody Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Arginase 1 Antibody Revenue by Type (2021-2026) & (k units) Table 25. Global Arginase 1 Antibody Revenue by Type (2027-2032) & (k units) Table 26. Global Arginase 1 Antibody Revenue Market Share by Type (2021-2026) Table 27. Global Arginase 1 Antibody Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Immunofluorescence Table 29. Major Manufacturers of Immunoprecipitation Table 30. Major Manufacturers of ELISA Table 31. Major Manufacturers of Flow Cytometry Table 32. Major Manufacturers of Western Blot Table 33. Major Manufacturers of Other Table 34. Global Arginase 1 Antibody Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Arginase 1 Antibody Sales by Application (2021-2026) & (k units) Table 36. Global Arginase 1 Antibody Sales by Application (2027-2032) & (k units) Table 37. Global Arginase 1 Antibody Sales Market Share by Application (2021-2026) Table 38. Global Arginase 1 Antibody Sales Market Share by Application (2027-2032) Table 39. Global Arginase 1 Antibody Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Arginase 1 Antibody Revenue by Application (2021-2026) & (k units) Table 41. Global Arginase 1 Antibody Revenue by Application (2027-2032) & (k units) Table 42. Global Arginase 1 Antibody Revenue Market Share by Application (2021-2026) Table 43. Global Arginase 1 Antibody Revenue Market Share by Application (2027-2032) Table 44. Global Arginase 1 Antibody Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Arginase 1 Antibody Sales by Region (2021-2026) & (k units) Table 46. Global Arginase 1 Antibody Sales Market Share by Region (2021-2026) Table 47. Global Arginase 1 Antibody Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Arginase 1 Antibody Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Arginase 1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Arginase 1 Antibody Sales by Country (2021-2026) & (k units) Table 51. North America Arginase 1 Antibody Sales by Country (2027-2032) & (k units) Table 52. Europe Arginase 1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Arginase 1 Antibody Sales by Country (2021-2026) & (k units) Table 54. Europe Arginase 1 Antibody Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Arginase 1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Arginase 1 Antibody Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Arginase 1 Antibody Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Arginase 1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Arginase 1 Antibody Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Arginase 1 Antibody Sales by Country (2027-2032) & (k units) Table 61. Global Arginase 1 Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Arginase 1 Antibody Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Arginase 1 Antibody Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Arginase 1 Antibody Revenue Market Share by Region (2021-2026) Table 65. Global Arginase 1 Antibody Revenue Market Share by Region (2027-2032) Table 66. Sino Biological, Inc. Company Information Table 67. Sino Biological, Inc. Business Overview Table 68. Sino Biological, Inc. Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sino Biological, Inc. Arginase 1 Antibody Product Portfolio Table 70. Sino Biological, Inc. Recent Development Table 71. Wuhan Fine Biotech Co., Ltd. Company Information Table 72. Wuhan Fine Biotech Co., Ltd. Business Overview Table 73. Wuhan Fine Biotech Co., Ltd. Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Wuhan Fine Biotech Co., Ltd. Arginase 1 Antibody Product Portfolio Table 75. Wuhan Fine Biotech Co., Ltd. Recent Development Table 76. Shanghai Korain Biotech Co., Ltd. Company Information Table 77. Shanghai Korain Biotech Co., Ltd. Business Overview Table 78. Shanghai Korain Biotech Co., Ltd. Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Shanghai Korain Biotech Co., Ltd. Arginase 1 Antibody Product Portfolio Table 80. Shanghai Korain Biotech Co., Ltd. Recent Development Table 81. Thermo Fisher Company Information Table 82. Thermo Fisher Business Overview Table 83. Thermo Fisher Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Thermo Fisher Arginase 1 Antibody Product Portfolio Table 85. Thermo Fisher Recent Development Table 86. ZodelBiotec Ltd. Company Information Table 87. ZodelBiotec Ltd. Business Overview Table 88. ZodelBiotec Ltd. Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. ZodelBiotec Ltd. Arginase 1 Antibody Product Portfolio Table 90. ZodelBiotec Ltd. Recent Development Table 91. ZellBio GmbH Company Information Table 92. ZellBio GmbH Business Overview Table 93. ZellBio GmbH Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. ZellBio GmbH Arginase 1 Antibody Product Portfolio Table 95. ZellBio GmbH Recent Development Table 96. MyBiosource, Inc. Company Information Table 97. MyBiosource, Inc. Business Overview Table 98. MyBiosource, Inc. Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. MyBiosource, Inc. Arginase 1 Antibody Product Portfolio Table 100. MyBiosource, Inc. Recent Development Table 101. Innovative Research Company Information Table 102. Innovative Research Business Overview Table 103. Innovative Research Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Innovative Research Arginase 1 Antibody Product Portfolio Table 105. Innovative Research Recent Development Table 106. Geno Technology, Inc. Company Information Table 107. Geno Technology, Inc. Business Overview Table 108. Geno Technology, Inc. Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Geno Technology, Inc. Arginase 1 Antibody Product Portfolio Table 110. Geno Technology, Inc. Recent Development Table 111. CUSABIO Company Information Table 112. CUSABIO Business Overview Table 113. CUSABIO Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. CUSABIO Arginase 1 Antibody Product Portfolio Table 115. CUSABIO Recent Development Table 116. Creative Diagnostics Company Information Table 117. Creative Diagnostics Business Overview Table 118. Creative Diagnostics Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Creative Diagnostics Arginase 1 Antibody Product Portfolio Table 120. Creative Diagnostics Recent Development Table 121. CLOUD-CLONE CORP. Company Information Table 122. CLOUD-CLONE CORP. Business Overview Table 123. CLOUD-CLONE CORP. Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. CLOUD-CLONE CORP. Arginase 1 Antibody Product Portfolio Table 125. CLOUD-CLONE CORP. Recent Development Table 126. Biomatik Company Information Table 127. Biomatik Business Overview Table 128. Biomatik Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Biomatik Arginase 1 Antibody Product Portfolio Table 130. Biomatik Recent Development Table 131. Assay Genie Company Information Table 132. Assay Genie Business Overview Table 133. Assay Genie Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Assay Genie Arginase 1 Antibody Product Portfolio Table 135. Assay Genie Recent Development Table 136. Abbexa Company Information Table 137. Abbexa Business Overview Table 138. Abbexa Arginase 1 Antibody Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Abbexa Arginase 1 Antibody Product Portfolio Table 140. Abbexa Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Arginase 1 Antibody Distributors List Table 144. Arginase 1 Antibody Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Arginase 1 Antibody Product Image Figure 2. Global Arginase 1 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arginase 1 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Arginase 1 Antibody Sales (2021-2032) & (k units) Figure 5. Global Arginase 1 Antibody Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Arginase 1 Antibody Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Monoclonal Antibody Image Figure 9. Polyclonal Antibody Image Figure 10. Global Arginase 1 Antibody Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Arginase 1 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Arginase 1 Antibody Sales Market Share by Type (2021-2032) Figure 13. Global Arginase 1 Antibody Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Arginase 1 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Arginase 1 Antibody Revenue Market Share by Type (2021-2032) Figure 16. Immunofluorescence Image Figure 17. Immunoprecipitation Image Figure 18. ELISA Image Figure 19. Flow Cytometry Image Figure 20. Western Blot Image Figure 21. Other Image Figure 22. Global Arginase 1 Antibody Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Arginase 1 Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Arginase 1 Antibody Sales Market Share by Application (2021-2032) Figure 25. Global Arginase 1 Antibody Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Arginase 1 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Arginase 1 Antibody Revenue Market Share by Application (2021-2032) Figure 28. North America Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Arginase 1 Antibody Sales Market Share by Country (2021-2032) Figure 30. U.S. Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Arginase 1 Antibody Sales Market Share by Country (2021-2032) Figure 35. Germany Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Arginase 1 Antibody Sales Market Share by Country (2021-2032) Figure 42. China Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Arginase 1 Antibody Sales Market Share by Country (2021-2032) Figure 50. Brazil Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Arginase 1 Antibody Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Arginase 1 Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Arginase 1 Antibody Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Arginase 1 Antibody Revenue (2021-2032) & (US$ Million) Figure 61. North America Arginase 1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Arginase 1 Antibody Revenue (2021-2032) & (US$ Million) Figure 63. Europe Arginase 1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Arginase 1 Antibody Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Arginase 1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Arginase 1 Antibody Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Arginase 1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Arginase 1 Antibody Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Arginase 1 Antibody Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibody
  • Polyclonal Antibody
Applications
  • Immunofluorescence
  • Immunoprecipitation
  • ELISA
  • Flow Cytometry
  • Western Blot
  • Other
Companies covered
  • Sino Biological, Inc.
  • Wuhan Fine Biotech Co., Ltd.
  • Shanghai Korain Biotech Co., Ltd.
  • Thermo Fisher
  • ZodelBiotec Ltd.
  • ZellBio GmbH
  • MyBiosource, Inc.
  • Innovative Research
  • Geno Technology, Inc.
  • CUSABIO
  • Creative Diagnostics
  • CLOUD-CLONE CORP.
  • Biomatik
  • Assay Genie
  • Abbexa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Arginase 1 Antibody Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Arginase 1 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Arginase 1 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Arginase 1 Antibody Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Arginase 1 Antibody Market Dynamics
  1. 2.1 Arginase 1 Antibody Industry Trends
  2. 2.2 Arginase 1 Antibody Industry Drivers
  3. 2.3 Arginase 1 Antibody Industry Opportunities and Challenges
  4. 2.4 Arginase 1 Antibody Industry Restraints
3 Arginase 1 Antibody Market by Manufacturers
  1. 3.1 Global Arginase 1 Antibody Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Arginase 1 Antibody Sales by Manufacturers (2021-2026)
  3. 3.3 Global Arginase 1 Antibody Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Arginase 1 Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Arginase 1 Antibody Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Arginase 1 Antibody Manufacturers, Product Type & Application
  7. 3.7 Global Arginase 1 Antibody Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Arginase 1 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Arginase 1 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Arginase 1 Antibody Tier 1, Tier 2, and Tier 3
4 Arginase 1 Antibody Market by Type
  1. 4.1 Arginase 1 Antibody Type Introduction
  2. 4.1.1 Monoclonal Antibody
  3. 4.1.2 Polyclonal Antibody
  4. 4.2 Global Arginase 1 Antibody Sales by Type
  5. 4.2.1 Global Arginase 1 Antibody Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Arginase 1 Antibody Sales by Type (2021-2032)
  7. 4.2.3 Global Arginase 1 Antibody Sales Market Share by Type (2021-2032)
  8. 4.3 Global Arginase 1 Antibody Revenue by Type
  9. 4.3.1 Global Arginase 1 Antibody Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Arginase 1 Antibody Revenue by Type (2021-2032)
  11. 4.3.3 Global Arginase 1 Antibody Revenue Market Share by Type (2021-2032)
5 Arginase 1 Antibody Market by Application
  1. 5.1 Arginase 1 Antibody Application Introduction
  2. 5.1.1 Immunofluorescence
  3. 5.1.2 Immunoprecipitation
  4. 5.1.3 ELISA
  5. 5.1.4 Flow Cytometry
  6. 5.1.5 Western Blot
  7. 5.1.6 Other
  8. 5.2 Global Arginase 1 Antibody Sales by Application
  9. 5.2.1 Global Arginase 1 Antibody Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Arginase 1 Antibody Sales by Application (2021-2032)
  11. 5.2.3 Global Arginase 1 Antibody Sales Market Share by Application (2021-2032)
  12. 5.3 Global Arginase 1 Antibody Revenue by Application
  13. 5.3.1 Global Arginase 1 Antibody Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Arginase 1 Antibody Revenue by Application (2021-2032)
  15. 5.3.3 Global Arginase 1 Antibody Revenue Market Share by Application (2021-2032)
6 Global Arginase 1 Antibody Sales by Region
  1. 6.1 Global Arginase 1 Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Arginase 1 Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global Arginase 1 Antibody Sales by Region (2021-2026)
  4. 6.2.2 Global Arginase 1 Antibody Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Arginase 1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Arginase 1 Antibody Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Arginase 1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Arginase 1 Antibody Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Arginase 1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Arginase 1 Antibody Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Arginase 1 Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Arginase 1 Antibody Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Arginase 1 Antibody Revenue by Region
  1. 7.1 Global Arginase 1 Antibody Revenue by Region
  2. 7.1.1 Global Arginase 1 Antibody Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Arginase 1 Antibody Revenue by Region (2021-2026)
  4. 7.1.3 Global Arginase 1 Antibody Revenue by Region (2027-2032)
  5. 7.1.4 Global Arginase 1 Antibody Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Arginase 1 Antibody Revenue (2021-2032)
  8. 7.2.2 North America Arginase 1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Arginase 1 Antibody Revenue (2021-2032)
  11. 7.3.2 Europe Arginase 1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Arginase 1 Antibody Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Arginase 1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Arginase 1 Antibody Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Arginase 1 Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sino Biological, Inc.
  2. 8.1.1 Sino Biological, Inc. Company Information
  3. 8.1.2 Sino Biological, Inc. Business Overview
  4. 8.1.3 Sino Biological, Inc. Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sino Biological, Inc. Arginase 1 Antibody Product Portfolio
  6. 8.1.5 Sino Biological, Inc. Recent Developments
  7. 8.2 Wuhan Fine Biotech Co., Ltd.
  8. 8.2.1 Wuhan Fine Biotech Co., Ltd. Company Information
  9. 8.2.2 Wuhan Fine Biotech Co., Ltd. Business Overview
  10. 8.2.3 Wuhan Fine Biotech Co., Ltd. Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Wuhan Fine Biotech Co., Ltd. Arginase 1 Antibody Product Portfolio
  12. 8.2.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
  13. 8.3 Shanghai Korain Biotech Co., Ltd.
  14. 8.3.1 Shanghai Korain Biotech Co., Ltd. Company Information
  15. 8.3.2 Shanghai Korain Biotech Co., Ltd. Business Overview
  16. 8.3.3 Shanghai Korain Biotech Co., Ltd. Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Korain Biotech Co., Ltd. Arginase 1 Antibody Product Portfolio
  18. 8.3.5 Shanghai Korain Biotech Co., Ltd. Recent Developments
  19. 8.4 Thermo Fisher
  20. 8.4.1 Thermo Fisher Company Information
  21. 8.4.2 Thermo Fisher Business Overview
  22. 8.4.3 Thermo Fisher Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Arginase 1 Antibody Product Portfolio
  24. 8.4.5 Thermo Fisher Recent Developments
  25. 8.5 ZodelBiotec Ltd.
  26. 8.5.1 ZodelBiotec Ltd. Company Information
  27. 8.5.2 ZodelBiotec Ltd. Business Overview
  28. 8.5.3 ZodelBiotec Ltd. Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ZodelBiotec Ltd. Arginase 1 Antibody Product Portfolio
  30. 8.5.5 ZodelBiotec Ltd. Recent Developments
  31. 8.6 ZellBio GmbH
  32. 8.6.1 ZellBio GmbH Company Information
  33. 8.6.2 ZellBio GmbH Business Overview
  34. 8.6.3 ZellBio GmbH Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ZellBio GmbH Arginase 1 Antibody Product Portfolio
  36. 8.6.5 ZellBio GmbH Recent Developments
  37. 8.7 MyBiosource, Inc.
  38. 8.7.1 MyBiosource, Inc. Company Information
  39. 8.7.2 MyBiosource, Inc. Business Overview
  40. 8.7.3 MyBiosource, Inc. Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MyBiosource, Inc. Arginase 1 Antibody Product Portfolio
  42. 8.7.5 MyBiosource, Inc. Recent Developments
  43. 8.8 Innovative Research
  44. 8.8.1 Innovative Research Company Information
  45. 8.8.2 Innovative Research Business Overview
  46. 8.8.3 Innovative Research Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Innovative Research Arginase 1 Antibody Product Portfolio
  48. 8.8.5 Innovative Research Recent Developments
  49. 8.9 Geno Technology, Inc.
  50. 8.9.1 Geno Technology, Inc. Company Information
  51. 8.9.2 Geno Technology, Inc. Business Overview
  52. 8.9.3 Geno Technology, Inc. Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Geno Technology, Inc. Arginase 1 Antibody Product Portfolio
  54. 8.9.5 Geno Technology, Inc. Recent Developments
  55. 8.10 CUSABIO
  56. 8.10.1 CUSABIO Company Information
  57. 8.10.2 CUSABIO Business Overview
  58. 8.10.3 CUSABIO Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CUSABIO Arginase 1 Antibody Product Portfolio
  60. 8.10.5 CUSABIO Recent Developments
  61. 8.11 Creative Diagnostics
  62. 8.11.1 Creative Diagnostics Company Information
  63. 8.11.2 Creative Diagnostics Business Overview
  64. 8.11.3 Creative Diagnostics Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Creative Diagnostics Arginase 1 Antibody Product Portfolio
  66. 8.11.5 Creative Diagnostics Recent Developments
  67. 8.12 CLOUD-CLONE CORP.
  68. 8.12.1 CLOUD-CLONE CORP. Company Information
  69. 8.12.2 CLOUD-CLONE CORP. Business Overview
  70. 8.12.3 CLOUD-CLONE CORP. Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CLOUD-CLONE CORP. Arginase 1 Antibody Product Portfolio
  72. 8.12.5 CLOUD-CLONE CORP. Recent Developments
  73. 8.13 Biomatik
  74. 8.13.1 Biomatik Company Information
  75. 8.13.2 Biomatik Business Overview
  76. 8.13.3 Biomatik Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biomatik Arginase 1 Antibody Product Portfolio
  78. 8.13.5 Biomatik Recent Developments
  79. 8.14 Assay Genie
  80. 8.14.1 Assay Genie Company Information
  81. 8.14.2 Assay Genie Business Overview
  82. 8.14.3 Assay Genie Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Assay Genie Arginase 1 Antibody Product Portfolio
  84. 8.14.5 Assay Genie Recent Developments
  85. 8.15 Abbexa
  86. 8.15.1 Abbexa Company Information
  87. 8.15.2 Abbexa Business Overview
  88. 8.15.3 Abbexa Arginase 1 Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Abbexa Arginase 1 Antibody Product Portfolio
  90. 8.15.5 Abbexa Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Arginase 1 Antibody Value Chain Analysis
  2. 9.1.1 Arginase 1 Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Arginase 1 Antibody Production Mode & Process
  6. 9.2 Arginase 1 Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Arginase 1 Antibody Distributors
  9. 9.2.3 Arginase 1 Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst